Status:

RECRUITING

Coping After Loss Through Mindfulness in Adults With Prolonged Grief Disorder

Lead Sponsor:

University Hospital, Caen

Collaborating Sponsors:

Northeastern University

Institut National de la Santé Et de la Recherche Médicale, France

Conditions:

Prolonged Grief Disorder

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to pilot the effectiveness of an 8-week standardized Mindfulness Training program to decrease the psychiatric and somatic symptoms of prolonged grief disorder (PGD) ...

Detailed Description

Bereavement is a major life stressor that triggers a stress response that can last months or years after the death of a loved one. This condition of persisting grief response called Prolonged Grief Di...

Eligibility Criteria

Inclusion

  • Must have lost a loved one (spouse, romantic partner, parent, child, sibling, close friend)
  • Must have a score \>29 on the Inventory of Complicated Grief (ICG)
  • Clinical diagnosis of Prolonged Grief Disorder as assessed by the Structured Clinical Interview for Complicated Grief (SCI-CG)

Exclusion

  • History of a lifetime clinical diagnosis of schizophrenia
  • History of a lifetime clinical diagnosis of bipolar disorder
  • History of a lifetime clinical diagnosis of a psychotic disorder
  • Current diagnosis of substance or alcohol use disorder within the past 12 months
  • History of a neurologic disease, seizures, stroke or head injury resulting in prolonged loss of consciousness and/or neurological sequelae
  • Current pregnancy as assessed by a urinary pregnancy test at screening during the Screening (week -4 until 0), Baseline (week 0) or Endpoint visit (week 8), or lack of use approved methods birth control for women of childbearing age
  • Currently practice of mind-body techniques at least once a week (e.g., yoga) in the past 3 months
  • Currently undergoing concomitant psychotherapy for grief (any psychotherapy)
  • Left-handedness
  • Current use of medications that would affect cerebral metabolism
  • Any contraindications to Magnetic Resonance Imaging (MRI)
  • Being under legal guardianship

Key Trial Info

Start Date :

August 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 31 2026

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06017765

Start Date

August 1 2023

End Date

July 31 2026

Last Update

July 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Caen et Université de Caen Normandie - Centre Esquirol Adult Psychiatry

Caen, Calvados, France, 14000